Postdoctoral Research Fellow, Australian Institute for Bioengineering and Nanotechnology
The Australian Institute for Bioengineering and Nanotechnology
The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is a dynamic multi-disciplinary research institute dedicated to developing technology to alleviate societal problems in the areas of health, energy, manufacturing and environmental sustainability. AIBN brings together the skills of more than 450 world-class researchers complimented by an extensive suite of integrated facilities, working at the intersection of biology, chemistry, engineering and computer modelling.
With a reputation for delivering translational science, AIBN conducts research at the forefront of emerging technologies, and has developed strong collaborations with leading members of industry, academia and government. AIBN goes beyond basic research to develop the growth of innovative industries for the benefit of the Queensland and Australian economies.
Our people are our greatest asset. We offer collaborative, inclusive work and study places, which are enriched by the significant diversity of our staff, students and community. We genuinely believe that creativity and innovation flourishes in an environment where people feel supported, valued and empowered. Mutual respect, inclusivity and accountability are at the cornerstone of UQ’s culture.
AIBN is committed to supporting the career growth of women researchers and have a number of initiatives to support women in developing and achieving a fulfilling research career at the institute. For more information, please visit our AIBN Women in Science web site at http://www.aibn.uq.edu.au/women.
The primary purpose of this position is to perform research into the potential of complement proteins as therapeutic targets for cancer. The successful candidate will join the laboraties of Dr Barbara Rolfe and A/Prof Trent Woodruff and be involved in the development of cell-based and in vivo assays for drug screening, mechanistic studies and biomarker identification. You will establish experimental cancer models, perform immunological assays and data analysis as well as develop and optimize flow cytometry assays, immunoassay techniques and cell-based assays using animal and human cells.
Applicants should have a PhD in the area of immunology, cell biology or related discipline with demonstrated knowledge in cell and molecular biology. Experience in molecular biology techniques, cell culture and in vitro assays (e.g. flow cytometry, cell-based assays, ELISA), and the ability to independently research and develop experimental procedures to solve a given problem is essential. Knowledge in cancer immunotherapy and experience with mouse cancer models is desirable.
The University of Queensland values diversity and inclusion and actively encourages applications from those who bring diversity to the University. Please refer to the University’s Diversity and Inclusion webpage (http://www.uq.edu.au/equity) for further information and points of contact if you require additional support.
This is a full-time, fixed-term appointment for two (2) years at Research Academic Level A. The remuneration package will be in the range $83,295 - $89,285 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range $97,456 - $104,464 p.a.). Flexible work arrangements may negotiated.
To discuss this role please contact Dr Barbara Rolfe via email email@example.com
To submit an application for this role, use the Apply button below. All applicants must supply the following documents: Cover letter, Resume and Selection Criteria responses.
For information on completing the application process click here.
Important: please do not send your application directly to the email listed in the enquiries section of the advertisement. Applications not received via UQ Jobs online system will not be considered.
Application closing date
10 January 2019 at 11:55 pm E. Australia Standard Time